Maria-Victoria Mateos

Maria-Victoria Mateos

UNVERIFIED PROFILE

Are you Maria-Victoria Mateos?   Register this Author

Register author
Maria-Victoria Mateos

Maria-Victoria Mateos

Publications by authors named "Maria-Victoria Mateos"

Are you Maria-Victoria Mateos?   Register this Author

100Publications

4826Reads

25Profile Views

Understanding mortality in multiple myeloma: Findings of a European retrospective chart review.

Eur J Haematol 2019 Aug 18;103(2):107-115. Epub 2019 Jun 18.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13264DOI Listing
August 2019

Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016.

Br J Haematol 2019 Jun 22;185(5):981-984. Epub 2018 Nov 22.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15680DOI Listing
June 2019

Improving the conditioning regimen in multiple myeloma.

Lancet Haematol 2019 May 22;6(5):e234-e235. Epub 2019 Mar 22.

Hematology Department, University Hospital of Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30028-6DOI Listing
May 2019

Management of cardiovascular risk in patients with multiple myeloma.

Blood Cancer J 2019 02 26;9(3):26. Epub 2019 Feb 26.

Hematology Service, University Hospital Salamanca, Casa del Bedel, Cardenal Pla y Deniel, 22, Planta Baja, Salamanca, 37008, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-019-0183-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391463PMC
February 2019

Lenalidomide as maintenance for every newly diagnosed patient with multiple myeloma.

Lancet Oncol 2019 Jan 14;20(1):5-6. Epub 2018 Dec 14.

Hematology Department, University Hospital of Salamanca, IBSAL, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30764-2DOI Listing
January 2019

Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients.

Eur J Intern Med 2018 12 12;58:57-63. Epub 2018 Jun 12.

Complejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2018.05.029DOI Listing
December 2018

Timing of treatment of smoldering myeloma: early treatment.

Blood Adv 2018 11;2(21):3045-3049

Complejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018021220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234377PMC
November 2018

Unusual report of non-syndromic permanent unilateral mandibular canine agenesis.

Dent Res J (Isfahan) 2018 Sep-Oct;15(5):372-377

Department of Stomatology, School of Dentistry, University of Sevilla, Sevilla, Spain.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134732PMC
September 2018

Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial.

J Clin Oncol 2018 07 2;36(20):2035-2043. Epub 2018 Feb 2.

Meletios Dimopoulos, National and Kapodistrian University of Athens, Athens, Greece; Katja Weisel, University Hospital of Tuebingen, Tuebingen, Germany; Niels W.C.J. van de Donk, VU Universiteit Medical Center, Amsterdam; Pieter Sonneveld, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Karthik Ramasamy, Oxford University Hospital and NIHR BRC Blood Theme, Oxford; Matthew Streetly, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Barbara Gamberi, Arcispedale S. Maria Nuova, Reggio Emilia; Massimo Offidani, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona; Antonio Ardizzoia, Oncology Department, ASST Lecco, Lecco, Italy; Frank Bridoux, University Hospital and University of Poitiers, Poitiers, France; Javier de la Rubia, Hematology Service University Hospital Doctor Peset and Universidad Católica de Valencia "San Vicente Mártir," Valencia; Maria-Victoria Mateos, Instituto de Investigación Biomédica de Salamanca and University of Salamanca, Salamanca, Spain; Elisabeth Kueenburg, Shona Collins, Antonia Di Micco, Barbara Rosettani, and Pamela Bacon, Celgene International, Boudry, Switzerland; and Yan Li, Translational Development and Clinical Pharmacology, Celgene Corporation, Summit, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.1742DOI Listing
July 2018

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.

N Engl J Med 2018 02 12;378(6):518-528. Epub 2017 Dec 12.

From University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca (M.-V.M.), and Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona (J.S.-M.) - both in Spain; National and Kapodistrian University of Athens, Athens (M.A.D.); the Institute of Hematology, Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna (M. Cavo), and Azienda Ospedaliera "Santa Maria," Terni (A.M.L.) - both in Italy; Japanese Red Cross Medical Center, Department of Hematology, Tokyo (K.S.); University of Chicago Medical Center, Chicago (A.J.); Würzburg University Medical Center, Würzburg, Germany (S.K.); Université Catholique de Louvain (UCL), Centre Hospitalier Universitaire UCL Namur, Yvoir (C.D.), and Janssen Research and Development, Beerse (W.D.) - both in Belgium; Champalimaud Center for the Unknown, Lisbon, Portugal (P.L.); Semmelweis Egyetem, Budapest, Hungary (Z.N.); Dnepropetrovsk City Clinical Hospital #4, Dnepropetrovsk, Ukraine (P.K.); University Hospital Brno, Brno, Czech Republic (L.P.); University Hospitals Birmingham NHS Foundation Trust, Birmingham (M. Cook), and Leicester Royal Infirmary-Haematology, Leicester (M.G.) - both in the United Kingdom; the Department of Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland (S.G.); Clínica de Tratamento E, Cuiaba, Brazil (A.C.); Andrew Love Cancer Centre, Geelong, VIC, Australia (P.C.); Clinic of Professional Pathology, Saratov, Russia (T.S.); the Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea (S.-S.Y.); LTD "Medinvent" Institute of Health, Tbilisi, Georgia (G.I.); Matsuyama Red Cross Hospital, Matsuyama, Japan (T.F.); Janssen Research and Development, Spring House, PA (C.C., R.C., W.C., M.Q.); and Janssen Research and Development, Raritan, NJ (J.W., H.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1714678DOI Listing
February 2018

A question of class: Treatment options for patients with relapsed and/or refractory multiple myeloma.

Crit Rev Oncol Hematol 2018 Jan 5;121:74-89. Epub 2017 Dec 5.

Department of Hematology, University of Nantes Health Centre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.11.016DOI Listing
January 2018

Myeloma in Elderly Patients: When Less Is More and More Is More.

Am Soc Clin Oncol Educ Book 2017 ;37:575-585

From The Ohio State University, Columbus, OH; Memorial Sloan Kettering Cancer Center, New York, NY; University Hospital of Salamanca, Salamanca, Spain; Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619424PMC
December 2017

Management of multiple myeloma in the newly diagnosed patient.

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):498-507

Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Navarra, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142596PMC
December 2017

Smoldering Multiple Myeloma: Who and When to Treat.

Clin Lymphoma Myeloma Leuk 2017 11 23;17(11):716-722. Epub 2017 Jun 23.

Hematology Department, Complejo Asistencial Universitario de Salamanca/Instituto Biosanitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.06.022DOI Listing
November 2017

When to initiate treatment in smoldering multiple myeloma.

Clin Adv Hematol Oncol 2017 Oct;15(10):751-753

Haematology Department, University Hospital of Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
October 2017

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials.

J Clin Oncol 2017 Sep 12;35(25):2900-2910. Epub 2017 May 12.

Juan-Jose Lahuerta, Maria-Teresa Cedena, Joaquin Martinez-Lopez, and María-Luisa Martín-Ramos, Hospital 12 de Octubre, CIBERONC; Raquel de Paz, Hospital Universitario La Paz; Rafael Martinez, Hospital Clínico San Carlos; Adrian Alegre, Hospital Universitario La Princesa, Madrid; Bruno Paiva and Jesus F. San-Miguel, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona; Laura Rosiñol, and Joan Blade, Hospital Clínic de Barcelona, Barcelona; Maria-Belen Vidriales, Noemi Puig, Norma C. Gutierrez, Alejandro Martin, and María-Victoria Mateos, Hospital Universitario de Salamanca Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBERONC; Alberto Orfao, Servicio General de Citometría-NUCLEOS, Centro de Investigación del Cancer (IBMCC-USAL, CSIC), IBSAL and Department of Medicine, Universidad de Salamanca, CIBERONC, Salamanca; Lourdes Cordón and Javier De la Rubia, Hospital Universitario y Politécnico La Fe; Ana-Isabel Teruel, Hospital Clínico de Valencia, Valencia; Albert Oriol, Hospital Germans Trias i Pujol, Badalona; María-Asunción Echeveste, Hospital de Donostia, San Sebastian; Felipe de Arriba, Hospital Morales Meseguer, Murcia; Miguel T. Hernandez, Hospital Universitario de Canarias, Tenerife; Luis Palomera, Hospital Universitario Lozano Blesa, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.2517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568033PMC
September 2017

Multiple myeloma.

Nat Rev Dis Primers 2017 Jul 20;3:17046. Epub 2017 Jul 20.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2017.46DOI Listing
July 2017

MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology.

Cancer Treat Res 2016;169:3-12

Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-40320-5_1DOI Listing
June 2017

Management of smoldering myeloma: Recommendations of the Spanish Myeloma Group.

Med Clin (Barc) 2017 06 22;148(11):517-523. Epub 2017 Mar 22.

Grupo Español de Mieloma (GEM)/PETHEMA; Clínica Universidad de Navarra, Pamplona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2017.02.012DOI Listing
June 2017

Plitidepsin: design, development, and potential place in therapy.

Drug Des Devel Ther 2017 19;11:253-264. Epub 2017 Jan 19.

Hematology Department, IBSAL-CIC-USAL, Hospital Universitario de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S94165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261604PMC
May 2017

Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case.

Clin Case Rep 2016 12 11;4(12):1096-1100. Epub 2016 Oct 11.

Department of Dermatology Complejo Asistencial Universitario de Salamanca/Instituto de investigación biomédica de Salamanca (CAUSA/IBSAL) Salamanca Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.706DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134131PMC
December 2016

Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma.

Br J Haematol 2016 Nov 19;175(3):448-456. Epub 2016 Jul 19.

Clinical and Translational Medicine, Clínica Universidad de Navarra - CIMA (Centro de Investigación Médica Aplicada) - IdiSNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14263DOI Listing
November 2016

Multiple myeloma: practice patterns across Europe.

Br J Haematol 2016 10 13;175(1):66-76. Epub 2016 Jun 13.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14193DOI Listing
October 2016

Multiple myeloma: patient outcomes in real-world practice.

Br J Haematol 2016 Oct 13;175(2):252-264. Epub 2016 Jul 13.

'Seràgnoli' Institute of Hematology and Medical Oncology, Bologna University School of Medicine, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096152PMC
October 2016

Update on elotuzumab, a novel anti-SLAMF7 monoclonal antibody for the treatment of multiple myeloma.

Expert Opin Biol Ther 2016 10 17;16(10):1291-301. Epub 2016 Aug 17.

d Jerome Lipper Multiple Myeloma Center , Dana-Farber Cancer Institute , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2016.1221920DOI Listing
October 2016

[Primary amyloidosis].

Med Clin (Barc) 2016 08 13;147(3):121-6. Epub 2016 Apr 13.

Complejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.02.018DOI Listing
August 2016

Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review.

Thromb Res 2016 May 5;141:84-90. Epub 2016 Mar 5.

University of Western Ontario, Hematology Division, London, Ontario, Canada; Hematology Division, London Health Sciences Center, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2016.03.006DOI Listing
May 2016

Smoldering multiple myeloma: when to observe and when to treat?

Am Soc Clin Oncol Educ Book 2015 :e484-92

From the University Hospital of Salamanca/IBSAL, Salamanca, Spain; Clínica Universidad de Navarra/CIMA, Navarra, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e484DOI Listing
February 2016

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma.

Blood 2016 Feb 2;127(6):681-95. Epub 2015 Dec 2.

Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-10-646810DOI Listing
February 2016

Treatment for patients with newly diagnosed multiple myeloma in 2015.

Blood Rev 2015 Nov 12;29(6):387-403. Epub 2015 Jun 12.

Clínica Universidad de Navarra/Centro de Investigación Médica Aplicada (CIMA), Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2015.06.001DOI Listing
November 2015

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.

N Engl J Med 2015 Aug 2;373(7):621-31. Epub 2015 Jun 2.

From Winship Cancer Institute, Emory University School of Medicine, Atlanta (S.L.); National and Kapodistrian University of Athens, Athens (M.D.); A.O.U. San Giovanni Battista di Torino-Ospedale Molinette, Turin, Italy (A.P.); QEII Health Science Center and Dalhousie University, Halifax, NS (D.W.), Cross Cancer Institute and University of Alberta, Edmonton (A.B.), and Princess Margaret Cancer Centre, Toronto (D.R.) - all in Canada; Silesian Medical University, Katowice (S.G.), and Medical University of Lublin, Lublin (A.W.-C.) - both in Poland; Charles University Hospital, Prague, Czech Republic (I.S.); University Hospital, Nantes, France (P.M.); Complejo Asistencial Universitario de Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca (M.-V.M.), and Clinica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona (J.S.-M.) - both in Spain; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Ramat Aviv - both in Israel (H.M.); Ankara University, Ankara, Turkey (M.B.); Alfred Health-Monash University, Melbourne, VIC, Australia (A. Spencer); Barts and the London NHS Trust, London (H.O.); University of Texas M.D. Anderson Cancer Center, Houston (R.Z.O.); Kyoto Prefectural University of Medicine, Kyoto (M.T.), and Nishigunma National Hospital, Shibukawa (M.M.) - both in Japan; Universitätsklinikum der Technische Universität, Dresden (C.R.), and Universitätsklinikum Würzburg, Würzburg (H.E.) - both in Germany; Zeikenhuis Netwerk Antwerpen (ZNA) Stuivenberg, Antwerp, Belgium (K.L.W.); AbbVie Biotherapeutics, Redwood City, CA (A. Singhal); Bristol-Myers Squibb, Princeton, NJ (J.K.), Wallingford, CT (E.B.), and Braine-l'Alleud, Belgium (V.P.); and Dana-Farber Cancer Institute, Boston (K.C.A., P.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1505654DOI Listing
August 2015

Authors' Response.

Am J Hematol 2015 Aug;90(8):E146

Centro Investigación Medica Aplicada, Clinica Universidad De Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24079DOI Listing
August 2015

V. Smoldering multiple myeloma.

Hematol Oncol 2015 Jun;33 Suppl 1:33-7

Clínica Universidad de Navarra/CIMA, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.2213
Publisher Site
http://dx.doi.org/10.1002/hon.2213DOI Listing
June 2015

Smoldering multiple myeloma.

Blood 2015 May 2;125(20):3069-75. Epub 2015 Apr 2.

Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-09-568899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432003PMC
May 2015